Security key
00288U106
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL)
CUSIP: 00288U106
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 305,667,944
- Total 13F shares
- 117,984,795
- Share change
- +6,328,611
- Total reported value
- $1,259,732,308
- Put/Call ratio
- 41%
- Price per share
- $10.65
- Number of holders
- 160
- Value change
- +$77,596,210
- Number of buys
- 107
- Number of sells
- 46
Report period
Q2 2022
Institutions
160
Top holders
10
ABCL full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
AbCellera Biologics Inc. SEC filings
AbCellera Biologics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00288U106
Recent filing periods:
Top shareholders of ABCL - AbCellera Biologics Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
6%
|
18,267,775
|
$178,111,000 | — | 31 Mar 2022 | |
| Allianz Asset Management GmbH |
13F
|
Company |
3.7%
|
11,158,045
|
$108,791,000 | — | 31 Mar 2022 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
3.6%
|
11,048,765
|
$107,725,000 | — | 31 Mar 2022 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
3.4%
|
10,450,180
|
$101,889,000 | — | 31 Mar 2022 | |
| SB Management Ltd |
13F
|
Company |
2.5%
|
7,764,299
|
$75,702,000 | — | 31 Mar 2022 | |
| DCVC Bio GP, LLC |
13F
|
Company |
2.4%
|
7,305,761
|
$71,231,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.4%
|
4,180,768
|
$40,762,000 | — | 31 Mar 2022 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
1.3%
|
4,105,095
|
$40,025,000 | — | 31 Mar 2022 | |
| GUARDIAN CAPITAL ADVISORS LP |
13F
|
Company |
1.3%
|
3,836,414
|
$34,604,000 | — | 31 Mar 2022 | |
| Founders Fund VII Management, LLC |
13F
|
Company |
1.2%
|
3,773,530
|
$36,791,000 | — | 31 Mar 2022 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
1%
|
3,189,837
|
$31,100,000 | — | 31 Mar 2022 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.87%
|
2,654,714
|
$25,884,000 | — | 31 Mar 2022 | |
| Capital International Investors |
13F
|
Company |
0.86%
|
2,626,644
|
$25,610,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.86%
|
2,617,603
|
$25,522,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.8%
|
2,447,299
|
$23,861,000 | — | 31 Mar 2022 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.57%
|
1,731,812
|
$16,885,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.49%
|
1,493,996
|
$14,566,000 | — | 31 Mar 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.42%
|
1,288,000
|
$12,558,000 | — | 31 Mar 2022 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.38%
|
1,150,000
|
$11,212,000 | — | 31 Mar 2022 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.36%
|
1,111,979
|
$10,842,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.27%
|
827,293
|
$8,066,000 | — | 31 Mar 2022 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.22%
|
659,750
|
$6,433,000 | — | 31 Mar 2022 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.21%
|
628,130
|
$6,124,000 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
495,984
|
$4,836,000 | — | 31 Mar 2022 | |
| ArchPoint Investors |
13F
|
Company |
0.15%
|
461,289
|
$4,498,000 | — | 31 Mar 2022 | |
| Aberdeen Group plc |
13F
|
Company |
0.13%
|
410,452
|
$3,998,000 | — | 31 Mar 2022 | |
| Founders Fund Growth Management, LLC |
13F
|
Company |
0.13%
|
407,017
|
$3,968,000 | — | 31 Mar 2022 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.13%
|
393,776
|
$3,840,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
393,136
|
$3,834,000 | — | 31 Mar 2022 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.12%
|
356,626
|
$4,276,264 | — | 31 Mar 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.11%
|
322,856
|
$3,148,000 | — | 31 Mar 2022 | |
| Gruss & Co., LLC |
13F
|
Company |
0.09%
|
286,000
|
$2,789,000 | — | 31 Mar 2022 | |
| NORGES BANK |
13F
|
Company |
0.09%
|
285,369
|
$2,782,348 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
269,030
|
$2,623,000 | — | 31 Mar 2022 | |
| Jump Financial, LLC |
13F
|
Company |
0.08%
|
248,900
|
$2,427,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
248,070
|
$2,418,000 | — | 31 Mar 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.08%
|
246,303
|
$2,401,000 | — | 31 Mar 2022 | |
| Trexquant Investment LP |
13F
|
Company |
0.08%
|
230,872
|
$2,251,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
202,708
|
$1,976,000 | — | 31 Mar 2022 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.06%
|
187,000
|
$1,823,000 | — | 31 Mar 2022 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
186,809
|
$1,821,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
169,142
|
$1,649,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
150,882
|
$1,471,000 | — | 31 Mar 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.05%
|
149,417
|
$1,457,000 | — | 31 Mar 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.04%
|
136,910
|
$1,335,000 | — | 31 Mar 2022 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
129,882
|
$1,266,000 | — | 31 Mar 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
128,851
|
$1,256,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
128,512
|
$1,253,000 | — | 31 Mar 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.04%
|
128,502
|
$1,265,000 | — | 31 Mar 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.04%
|
123,900
|
$1,208,000 | — | 31 Mar 2022 |
Institutional Holders of AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) as of Q2 2022
As of 30 Jun 2022,
AbCellera Biologics Inc. - Common Shares, no par value per share (ABCL) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
117,984,795 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, Capital World Investors, BlackRock Inc., Allianz Asset Management GmbH, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, HARVARD MANAGEMENT CO INC, RENAISSANCE TECHNOLOGIES LLC, GUARDIAN CAPITAL ADVISORS LP, and Founders Fund VII Management, LLC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
126
Q2 2022 holders
160
Holder diff
34
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.